Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-04-14
DOI
https://doi.org/10.7326/annals-24-02870
Citations
14
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
19.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States

John W. Ostrominski, Elisabetta Patorno, Janinne Ortega-Montiel, Helen Tesfaye et al.
14 citations
Annals of Internal Medicine
Pharmacology and Obesity Treatment
19.52
article

Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States

John W. Ostrominski, Elisabetta Patorno, Janinne Ortega-Montiel, Helen Tesfaye, Deborah J. Wexler, SARA JANE CROMER, Julie M. Paik, Elyse DiCesare, CAROLINE ALIX
article en
14 citations

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(5)
Brigham and Women's Hospital (US), Harvard University (US), Massachusetts General Hospital (US)
Zero hunger
Openalex Percentile: Top 0%
Pharmacology and Obesity Treatment
19.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.